Additional information
| Active substance | Onabotulinumtoxina |
|---|---|
| Classification | Botulinum toxin type A |
| Acne | No |
| Water Retention | No |
| HBR | No |
| Hepatotoxicity | No |
| Aromatization | No |
| Lab Test | Mouse bioassay for potency testing |
| Also known as | Botox, onabotulinumtoxinA |
| WAREHOUSE | International Warehouse 2 |
| Blood pressure | No significant effect |
| Trade name | Botox, Dysport, Xeomin |
| Storage conditions | Refrigerated, 2-8В°C |
| Chemical name | Botulinum toxin type A |
| Formula | C6760H10447N1743O2010S32 |
| Substance class | Neurotoxin |
| Main action | Blocks the release of acetylcholine at neuromuscular junctions |
| Half-life | 2-6 months |
| Dosage (medical) | 20-100 units injected intramuscularly, depending on treatment area |
| Dosage (sports) | Not applicable |
| Effects | Reduces muscle activity, treats wrinkles, muscle spasms, and excessive sweating |
| Side effects | Pain at injection site, headache, muscle weakness, drooping eyelids, dysphagia, spread of toxin effects |
| Use in sports | None, usage in sports would be considered misuse |
| Manufacturer | Allergan |
Norvacs 10 mg Pfizer
Beginner Bulking Cycle Ultima Pharmaceuticals
Thyromazol 5 mg Abdi Ibragim
Januvia 100mg Merckgroup
Clomid 50 mg Magnus Pharmaceuticals
Fostimon (Merional) 150 IU HMG IBSA
Prograf 1mg Astellas Pharma
Champix Starter Pack Pfizer
Seretide Disckus (Advair) 250 mcg Glaxosmithkline 

Reviews
There are no reviews yet.